|
A more recent version of this article appeared on December 30, 2005
Papers In Press, published online ahead of print October 21, 2005
J. Biol. Chem, 10.1074/jbc.M509147200
Submitted on August 19, 2005
Revised on October 20, 2005
Accepted on October 21, 2005
PKC mediates testosterone-induced increases in coronary smooth muscle Cav1.2
Kamala K. Maddali, Donna H. Korzick, Darla L. Tharp, and Douglas K. Bowles
University of Missouri, Columbia, MO 65211
Corresponding Author: bowlesd{at}missouri.edu
Sex hormones have emerged as important modulators of cardiovascular physiology and pathophysiology. Our previous studies demonstrated that testosterone increases expression and activity of L-type, voltage-gated calcium channels (Cav1.2) in coronary arteries of males. The purpose of the present study was to determine if testosterone (T) alters coronary PKC expression and if PKC plays a role in coronary Cav1.2 expression. For in vitro studies, porcine right coronary arteries (RCA) and post confluent (passages 3-6) five-day, serum restricted coronary smooth muscle cell cultures (CSMC) were incubated in the presence and absence of T or dihydrotestosterone (DHT; 10 and 100nM) for 18 hours at 37oC in a humidified chamber. For sex and endogenous testosterone dependent effects, RCA were obtained from intact males (IM), castrated males (CM), CM with T replacement (CMT) and intact females (IF). In vitro T and DHT caused an ~2-3 fold increase in PKC protein levels, ~1.5-2 fold increase in PKC kinase activity and localization of PKC towards the plasma membrane and nuclear envelope. PKC protein levels were higher in coronary arteries of IM compared to IF. Elimination of endogenous testosterone by castration reduced RCA PKC protein levels, an effect partially (~45%) reversed by exogenous T (CMT). In CSMC, PKC inhibition with either the general PKC inhibitor, cheylerythrine, or the putative PKC inhibitor, rottlerin, completely inhibited the T-mediated increase in coronary Cav1.2 protein levels. Conversely, Go6976, a conventional PKC isoform inhibitor, failed to inhibit T-induced increases in coronary Cav1.2 protein levels. PKC siRNA completely blocked T induced increases in Cav1.2 protein levels in CSMC. These results demonstrate for the first time that 1) endogenous T is a primary modulator of coronary PKC protein and activity in males and 2) T increases Cav1.2 protein expression in a PKC dependent manner.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. K. Bowles, K. K. Maddali, V. C. Dhulipala, and D. H. Korzick
PKC{delta} mediates anti-proliferative, pro-apoptic effects of testosterone on coronary smooth muscle
Am J Physiol Cell Physiol,
August 1, 2007;
293(2):
C805 - C813.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Clavijo, J.-L. Chen, K.-J. Kim, M. E. Reyland, and D. K. Ann
Protein kinase C{delta}-dependent and -independent signaling in genotoxic response to treatment of desferroxamine, a hypoxia-mimetic agent
Am J Physiol Cell Physiol,
June 1, 2007;
292(6):
C2150 - C2160.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Cobine, B. P. Callaghan, and K. D. Keef
Role of L-type calcium channels and PKC in active tone development in rabbit coronary artery
Am J Physiol Heart Circ Physiol,
June 1, 2007;
292(6):
H3079 - H3088.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. V. Gavrielides, A. M. Gonzalez-Guerrico, N. A. Riobo, and M. G. Kazanietz
Androgens Regulate Protein Kinase C{delta} Transcription and Modulate Its Apoptotic Function in Prostate Cancer Cells
Cancer Res.,
December 15, 2006;
66(24):
11792 - 11801.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|